274 related articles for article (PubMed ID: 26036717)
1. How can we better predict the risk of spontaneous miscarriage among women experiencing threatened miscarriage?
Ku CW; Allen JC; Malhotra R; Chong HC; Tan NS; Østbye T; Lek SM; Lie D; Tan TC
Gynecol Endocrinol; 2015; 31(8):647-51. PubMed ID: 26036717
[TBL] [Abstract][Full Text] [Related]
2. Validation of serum progesterone <35nmol/L as a predictor of miscarriage among women with threatened miscarriage.
Lek SM; Ku CW; Allen JC; Malhotra R; Tan NS; Østbye T; Tan TC
BMC Pregnancy Childbirth; 2017 Mar; 17(1):78. PubMed ID: 28264669
[TBL] [Abstract][Full Text] [Related]
3. Progesterone - induced blocking factor (PIBF) and Th(1)/Th(2) cytokine in women with threatened spontaneous abortion.
Hudić I; Fatusić Z
J Perinat Med; 2009; 37(4):338-42. PubMed ID: 19290853
[TBL] [Abstract][Full Text] [Related]
4. Serum progesterone distribution in normal pregnancies compared to pregnancies complicated by threatened miscarriage from 5 to 13 weeks gestation: a prospective cohort study.
Ku CW; Allen JC; Lek SM; Chia ML; Tan NS; Tan TC
BMC Pregnancy Childbirth; 2018 Sep; 18(1):360. PubMed ID: 30185145
[TBL] [Abstract][Full Text] [Related]
5. The value of placental protein 13, β-human chorionic gonadotropin and progesterone in the prediction of miscarriages in threatened miscarriage patients.
Yalçin I; Taşkin S; Pabuçcu EG; Söylemez F
J Obstet Gynaecol; 2015 Apr; 35(3):283-6. PubMed ID: 25153203
[TBL] [Abstract][Full Text] [Related]
6. Maternal serum progesterone-induced blocking factor at 11-13 weeks' gestation in spontaneous early preterm delivery.
Beta J; Szekeres-Bartho J; Skyfta E; Akolekar R; Nicolaides KH
Fetal Diagn Ther; 2011; 29(3):197-200. PubMed ID: 21212635
[TBL] [Abstract][Full Text] [Related]
7. Characterisation of serum progesterone and progesterone-induced blocking factor (PIBF) levels across trimesters in healthy pregnant women.
Lim MK; Ku CW; Tan TC; Lee YHJ; Allen JC; Tan NS
Sci Rep; 2020 Mar; 10(1):3840. PubMed ID: 32123187
[TBL] [Abstract][Full Text] [Related]
8. Miscarriage in the first trimester according to the presence or absence of the progesterone-induced blocking factor at three to five weeks from conception in progesterone supplemented women.
Check JH; Levin E; Bollendorf A; Locuniak J
Clin Exp Obstet Gynecol; 2005; 32(1):13-4. PubMed ID: 15864927
[TBL] [Abstract][Full Text] [Related]
9. The impact of dydrogesterone supplementation on hormonal profile and progesterone-induced blocking factor concentrations in women with threatened abortion.
Kalinka J; Szekeres-Bartho J
Am J Reprod Immunol; 2005 Apr; 53(4):166-71. PubMed ID: 15760377
[TBL] [Abstract][Full Text] [Related]
10. Maternal serum progesterone-induced blocking factor (PIBF) in the prediction of preterm birth.
Hudić I; Stray-Pedersen B; Szekeres-Bartho J; Fatušić Z; Dizdarević-Hudić L; Tomić V; Polgar B; Hadžiefendić B; Fatušić J
J Reprod Immunol; 2015 Jun; 109():36-40. PubMed ID: 25818991
[TBL] [Abstract][Full Text] [Related]
11. Threatened miscarriage as a predictor of obstetric outcome.
Johns J; Jauniaux E
Obstet Gynecol; 2006 Apr; 107(4):845-50. PubMed ID: 16582121
[TBL] [Abstract][Full Text] [Related]
12. Dydrogesterone supplementation in women with threatened preterm delivery--the impact on cytokine profile, hormone profile, and progesterone-induced blocking factor.
Hudić I; Szekeres-Bartho J; Fatušić Z; Stray-Pedersen B; Dizdarević-Hudić L; Latifagić A; Hotić N; Kamerić L; Mandžić A
J Reprod Immunol; 2011 Dec; 92(1-2):103-7. PubMed ID: 22032897
[TBL] [Abstract][Full Text] [Related]
13. Do serum leptin levels have a role in the prediction of pregnancy outcome in case of threatened miscarriage?
Tommaselli GA; Di Spiezio Sardo A; Di Carlo C; Bifulco G; Cerrota G; Cirillo D; Greco E; Nappi C
Clin Endocrinol (Oxf); 2006 Dec; 65(6):772-5. PubMed ID: 17121529
[TBL] [Abstract][Full Text] [Related]
14. Doppler and biochemical assessment for the prediction of early pregnancy outcome in patients experiencing threatened spontaneous abortion.
Shehata NAA; Ali HAA; Hassan AEGMA; Katta MA; Ali ASF
Int J Gynaecol Obstet; 2018 Nov; 143(2):150-155. PubMed ID: 30058068
[TBL] [Abstract][Full Text] [Related]
15. Correlations of the expression of γδ T cells and their co-stimulatory molecules TIGIT, PD-1, ICOS and BTLA with PR and PIBF in the peripheral blood and decidual tissues of women with unexplained recurrent spontaneous abortion.
Liang Q; Tong L; Xiang L; Shen S; Pan C; Liu C; Zhang H
Clin Exp Immunol; 2021 Jan; 203(1):55-65. PubMed ID: 33017473
[TBL] [Abstract][Full Text] [Related]
16. Role of serum biomarkers in the prediction of outcome in women with threatened miscarriage: a systematic review and diagnostic accuracy meta-analysis.
Pillai RN; Konje JC; Tincello DG; Potdar N
Hum Reprod Update; 2016; 22(2):228-39. PubMed ID: 26663220
[TBL] [Abstract][Full Text] [Related]
17. Maternal serum hormone concentrations for prediction of adverse outcome in threatened miscarriage.
Johns J; Muttukrishna S; Lygnos M; Groome N; Jauniaux E
Reprod Biomed Online; 2007 Oct; 15(4):413-21. PubMed ID: 17908404
[TBL] [Abstract][Full Text] [Related]
18. The expression of a progesterone-induced immunomodulatory protein in pregnancy lymphocytes.
Szekeres-Bartho J; Faust Z; Varga P
Am J Reprod Immunol; 1995 Dec; 34(6):342-8. PubMed ID: 8607938
[TBL] [Abstract][Full Text] [Related]
19. Novel approach using serum progesterone as a triage to guide management of patients with threatened miscarriage: a prospective cohort study.
Tan TC; Ku CW; Kwek LK; Lee KW; Zhang X; Allen JC; Zhang VR; Tan NS
Sci Rep; 2020 Jun; 10(1):9153. PubMed ID: 32499581
[TBL] [Abstract][Full Text] [Related]
20. The randomised controlled trial of micronised progesterone and dydrogesterone (TRoMaD) for threatened miscarriage.
Siew JYS; Allen JC; Hui CYY; Ku CW; Malhotra R; Østbye T; Tan TC
Eur J Obstet Gynecol Reprod Biol; 2018 Sep; 228():319-324. PubMed ID: 30077119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
